First in Human Study to Assess Safety of VIS649 in Healthy Subjects
Clinical trial NCT03719443 · COMPLETED
Trial details
- NCT number
- NCT03719443
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-09
- Primary completion
- 2019-08-10
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.